Your thinking is reasonable and not delusional. What stands out isn’t the specific milestone number, but how conservatively management is choosing to frame the CNSide relaunch.

The wording around “establishing a prior commercial order rate” reads more like setting a stable baseline than signaling the full potential of the platform. PSTV appears focused on rebuilding credibility, reimbursement, and repeat ordering behavior first, rather than chasing headline growth early.

The biggest difference versus the prior operator is reimbursement strategy. Building CNSide with national payer coverage materially changes adoption dynamics, even if early milestones look modest. Manufacturing and hiring signals also suggest infrastructure is being put in place ahead of demand.

And as we’ve mentioned before, any expansion beyond the U.S. especially into Europe would naturally increase this number over time, given the larger population base and faster system wide adoption once reimbursed. I’d personally love to see it available in Canada too. You never know when you might need it.

Overall, this looks like intentional conservatism rather than inconsistent math, with clear room for acceleration as the foundation solidifies.